A ‘safe’ version of Ebola has been developed by researchers hoping to broaden opportunities to study the deadly virus. If approved by national regulatory authorities, the non-infectious virus could be studied in a broader variety of labs, removing a major roadblock to finding a cure.
Office of Strategic Communication